ClinConnect ClinConnect Logo
Search / Trial NCT03405701

IVM Versus IVF in High Antral Follicle Count Patients

Launched by MỸ ĐỨC HOSPITAL · Jan 13, 2018

Trial Information

Current as of July 21, 2025

Completed

Keywords

ClinConnect Summary

Women with PCOS and PCOM or high AFC: ≥24 Antral Follicles in Both Ovaries will be given the information about the study during the first consultation which is at least 2 weeks before having periods. On the second day of periods, women will be screened for eligibility by the treating clinicians. Women who met the inclusion criteria will be invited to participate in the study. Women will be randomized (1:1) to IVM or IVF- GnRH agonist triggering cycle using block randomization by an independent study coordinator via telephone, using a computer-generated random list (block size 2, 4, 6 or 8)....

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Women with high AFC (≥24 Antral Follicles in Both Ovaries), including PCOS plus PCO or high AFC
  • Having indications for ART
  • Having ≤ 2 IVM/IVF attempts
  • Permanent resident in Vietnam
  • Agree to have all embryos frozen on day 3
  • Agree to have ≤ 2 embryos transferred in a subsequent frozen transfer
  • Not participating in another IVF study at the same time
  • Exclusion Criteria:
  • Oocyte donation cycles
  • Pre-implantation genetic diagnosis (PGD) cycles

About Mỹ đức Hospital

Mỹ Đức Hospital is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. With a strong emphasis on ethical practices and patient safety, the hospital collaborates with reputable research organizations and healthcare professionals to conduct studies across various therapeutic areas. Committed to excellence in clinical research, Mỹ Đức Hospital leverages its state-of-the-art facilities and experienced staff to contribute valuable insights that enhance medical knowledge and treatment options for diverse patient populations.

Locations

Ho Chi Minh City, Tan Binh, Vietnam

Patients applied

0 patients applied

Trial Officials

Lan N Vuong, MD,PhD

Principal Investigator

Mỹ Đức Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials